{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:23:13Z","timestamp":1767374593906,"version":"3.38.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.ejphar.2010.08.034","type":"journal-article","created":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T08:43:11Z","timestamp":1283935391000},"page":"87-94","source":"Crossref","is-referenced-by-count":21,"title":["Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain"],"prefix":"10.1016","volume":"648","author":[{"suffix":"Jr.","given":"Joseph R.","family":"Holtman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Crooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Johnson-Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta P.","family":"Wala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.08.034_bb0005","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMra025411","article-title":"Opioid therapy for chronic pain","volume":"349","author":"Ballantine","year":"2003","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/AJP.0b013e31816b2f26","article-title":"Efficacy of opioids for chronic pain","volume":"24","author":"Ballantine","year":"2008","journal-title":"Clin. J. Pain"},{"key":"10.1016\/j.ejphar.2010.08.034_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produced disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2010.08.034_bb0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/jps.2600740804","article-title":"Analgesic potencies of morphine 3- and 6-sulfates after intracerebroventricular administration in mice: relationship to structural characteristics defined by mass spectrometry and nuclear magnetic resonance","volume":"74","author":"Brown","year":"1985","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0025","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1016\/j.bmcl.2006.05.060","article-title":"Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine- 6-O-sulfate ester congeners","volume":"16","author":"Crooks","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3565(25)03823-6","article-title":"A method for determining loss of pain sensation","volume":"72","author":"D'Amour","year":"1941","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0035","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)39122-6","article-title":"Chemical characterization and regulation of endogenous morphine and codeine in the rat","volume":"242","author":"Donnerer","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0040","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses pacitaxel- and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2010.08.034_bb0045","first-page":"14","article-title":"Development of opioid tolerance: molecular mechanisms and clinical consequences","volume":"38","author":"Frey","year":"2003","journal-title":"Anesthesiol. Intensivmed. Notfallmed. Schmerzther."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pbb.2003.12.020","article-title":"Morphine tolerance in male and female rats","volume":"77","author":"Holtman","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0055","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0091-3057(95)02067-5","article-title":"3-O-Acetylmorphine-6-O-sulfate: a potent centrally acting morphine derivative","volume":"53","author":"Houdi","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0031-6997(24)01514-X","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0065","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0022-3565(24)29197-7","article-title":"Pharmacology of opioid and nonopioid analgesics in chronic pain states","volume":"299","author":"Martin","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.pbb.2004.12.002","article-title":"A preclinical comparison between different opioids; antinociceptive versus adverse effects","volume":"80","author":"Meert","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0075","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0885-3924(97)00371-0","article-title":"Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats","volume":"15","author":"Megens","year":"1998","journal-title":"J. Pain Symptom Manage."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0080","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0024-3205(72)90003-3","article-title":"Chemical synthesis and analgesic effects of morphine ethernal sulfates","volume":"11","author":"Mori","year":"1972","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0085","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/S0024-3205(00)00825-0","article-title":"Characteristic glucuronidation pattern of physiologic concentrations of morphine in rat brain","volume":"67","author":"Nagano","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0090","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/0024-3205(87)90710-7","article-title":"Enhanced binding of morphine and nalorphine to delta receptor by glucuronate and sulfate conjugates at the 6-position","volume":"41","author":"Oguri","year":"1987","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0095","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0024-3205(01)01008-6","article-title":"Insights into mu opioid pharmacology: the role of mu-opioid receptor subtypes","volume":"68","author":"Pasternak","year":"2001","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0100","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3565(25)20832-1","article-title":"Pharmacological characterization of morphine-6-\u03b2-glucuronide, a very potent morphine metabolite","volume":"251","author":"Paul","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2007.01.059","article-title":"Opioid efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2","volume":"563","author":"Pawar","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0110","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/jpet.103.055590","volume":"307","author":"Petrillo","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-2999(01)01308-5","article-title":"Opioids in chronic pain","volume":"429","author":"Przewlocki","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0120","first-page":"409","article-title":"A method for measurement of analgesic activity on inflamed tissue","volume":"111","author":"Randall","year":"1957","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1191\/0968130201pr183ra","article-title":"The role of morphine-6-glucuronide (M6G) in pain control","volume":"8","author":"Smith","year":"2001","journal-title":"Pain Rev."},{"year":"1987","series-title":"Manual of pharmacological calculations with computer program","author":"Tallarida","key":"10.1016\/j.ejphar.2010.08.034_bb0130"},{"key":"10.1016\/j.ejphar.2010.08.034_bb0135","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1213\/01.ane.0000217197.96784.c3","article-title":"Morphine-6-glucuronide: morphine's successor for postoperative pain relief","volume":"102","author":"Van Dorp","year":"2006","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0140","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/jps.2600531142","article-title":"Semiautomatic system for timing rotarod performance","volume":"53","author":"Watzman","year":"1964","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02244551","article-title":"Standardization of the rat paw formalin test for evaluation of analgesics","volume":"104","author":"Wheeler-Aceto","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2010.08.034_bb0150","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2010.08.034_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(99)01766-7","article-title":"Pharmacological characterization of morphine-S-sulfate and codeine-S-sulfate","volume":"1842","author":"Zuckerman","year":"1999","journal-title":"Brain Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910008381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910008381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:54:32Z","timestamp":1740502472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910008381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":31,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0014299910008381"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.08.034","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}